Use of desirability functions to evaluate health status in patients with cirrhosis

Journal of Hepatology

Volumn 52, Issue 5, 2010, Pages 665-671

  Gennings, Chris ^a,b   Heuman, Douglas ^c,d   Fulton, Otis ^e   Sanyal, Arun J ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Solveritas LLC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Metametrics Corporation   (United States)

Author keywords

Composite score; MELD; Uni dimensional scaling

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; SERUM ALBUMIN; SODIUM;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CIRRHOSIS RELATIVE WELLNESS INDEX; CREATININE BLOOD LEVEL; DESIRABILITY FUNCTION; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENTAL HEALTH; PILOT STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURVIVAL; THROMBOCYTE; VALIDATION STUDY;

DISEASE-FREE SURVIVAL; HEALTH STATUS; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MENTAL STATUS SCHEDULE; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROPORTIONAL HAZARDS MODELS; QUALITY ASSURANCE, HEALTH CARE; REPRODUCIBILITY OF RESULTS; SOCIAL DESIRABILITY; TIME FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 77951653014     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.12.026     Document Type: Article

References (12)

1. Harrington E.C. The desirability function. Ind Qual Control 21 (1965) 494-498
2. Derringer G., and Suich R. Simultaneous optimization of several response variables. J Qual Technol 12 (1980) 214-219
3. Derringer G. A balancing act: optimizing a product's properties. Qual Prog 27 (1994) 51-58
4. Gibb R.D., and Virginia Commonwealth University. Optimal treatment combination estimation for univariate and multivariate response surface applications (1998), Virginia Commonwealth University p. XI [289 leaves]
5. Wu F.C. Optimization of correlated multiple quality characteristics using desirability function. Qual Eng 17 (2005) 119-126
6. Coffey T., Gennings C., and Moser V.C. The simultaneous analysis of discrete and continuous outcomes in a dose-response study: using desirability functions. Regul Toxicol Pharmacol 48 (2007) 51-58
7. Shih M., Gennings C., Chinchilli V.M., and Carter W.H. Titrating and evaluating multi-drug regimens within subjects. Stat Med 22 (2003) 2257-2279
8. Sanyal A.J., Gennings C., Reddy K.R., Wong F., Kowdley K.W., Benner K., et al. The North American study for the treatment of refractory ascites. Gastroenterology 124 (2003) 634-641
9. Andrich D. Rasch models for measurement. Sage University papers series. Quantitative applications in the social sciences. Newbury Park: Sage Publications; 1988.
10. Horne B.D., May H.T., Muhlestein J.B., Ronnow B.S., Lappé D.L., Renlund D.G., et al. Exceptional mortality prediction by risk scores from common laboratory tests. Am J Med 122 (2009) 550-558
11. May H.T., Horne B.D., Ronnow B.S., Renlund D.G., Muhlestein J.B., Lappé D.L., et al. Superior predictive ability for death of a basic metabolic profile risk score. Am Heart J 157 (2009) 946-954
12. UNOS. United Network of Organ Sharing: Resources, Meld/Peld Calculator, [accessed 06.19.2009].